CIK 0001124105
- Accelerated filer
- Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562020050
- Phone
- +1 858-284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- 4 Grant or award Director acquired 1,036 shares (grant or award)
- 4 Grant or award Director acquired 1,810 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 1,000 shares at $8.03 ($8,030)
- 4 Exercise or conversion President & CEO acquired 4,400 shares (option exercise)
- 4 Exercise or conversion Chief Medical Officer acquired 4,400 shares (option exercise)
- 4 Grant or award Director acquired 1,364 shares (grant or award)
- 4 Grant or award Director acquired 2,414 shares (grant or award)
- 4 Grant or award Director acquired 717 shares (grant or award)
- 4 Grant or award Director acquired 1,504 shares (grant or award)
- 4/A Insider Changes in Ownership
- 4 Grant or award Chief Financial Officer acquired 1,002 shares (grant or award)
- 4 Grant or award President & CEO acquired 350 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 2,485 shares (grant or award)
- 4 Exercise or conversion Chief Medical Officer acquired 1,500 shares (option exercise)
- 4 Exercise or conversion Chief Financial Officer acquired 1,503 shares (option exercise)
Page 13 of 37 · 739 filings